Abstract
Purpose
This study was designed to assess the efficacy and safety of the ExoSeal vascular closure device (VCD) to achieve hemostasis in antegrade access of the superficial femoral artery (SFA).
Methods
We retrospectively reviewed the outcome of ExoSeal VCD used for hemostasis in 110 accesses to the SFA in 93 patients between July 2011 and July 2013. All patients had patent proximal SFA based on computer tomography angiography or ultrasound duplex. Arterial calcifications at puncture site were graded using fluoroscopy. The SFA was accessed in an antegrade fashion with ultrasound or fluoroscopic guidance. In all patients, 5–7F vascular sheaths were used. The ExoSeal VCD was applied to achieve hemostasis at the end of the procedure. All patients were clinically examined and had ultrasound duplex exam for any puncture site complications during the 24 h postprocedure.
Results
In all procedures, the ExoSeal was applied successfully. We did not encounter any device-related technical failure. There were four major complications in four patients (3.6 %): three pseudoaneurysms, which were treated with direct thrombin injection, and one hematoma, which necessitated transfusion of two blood units. All patients with complications were treated with anticoagulation preprocedure or received thrombolytic therapy.
Conclusions
The ExoSeal VCD can be safely used for antegrade puncture of the SFA, with a high procedural success rate (100 %) and a low rate of access site complications (3.6 %).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weitz JI, Byrne J, Clagett GP et al (1996) Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94:3026–3049
Fossaceca R, Guzzardi G, Cerini P et al (2013) Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective? Cardiovasc Intervent Radiol 36:637–644
Stone PA, Campbell JE (2012) Complications related to femoral artery access for transcatheter procedures. Vasc Endovascular Surg 46:617–623
Rapoport S, Sniderman KW, Morse SS, Proto MH, Ross GR (1985) Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology 154:529–530
Marcus AJ, Lotzof K, Howard A (2007) Access to the superficial femoral artery in the presence of a “hostile groin”: a prospective study. Cardiovasc Intervent Radiol 30:4–35135
Gutzeit A, Graf N, Schoch E et al (2011) Ultrasound-guided antegrade femoral access: comparison between the common femoral artery and the superficial femoral artery. Eur Radiol 21:1323–1328
Gutzeit A, Schie B, Schoch E et al (2012) Feasibility and safety of vascular closure devices in an antegrade approach to either the common femoral artery or the superficial femoral artery. Cardiovasc Intervent Radiol 35:1036–1040
Gutzeit A, Schoch E, Sautter T et al (2010) Antegrade access to the superficial femoral artery with ultrasound guidance: feasibility and safety. J Vasc Interv Radiol 21:1495–1500
Kweon M, Bhamidipaty V, Holden A, Hill AA (2012) Antegrade superficial femoral artery versus common femoral artery punctures for infrainguinal occlusive disease. J Vasc Interv Radiol 23:1160–1164
Wong SC, Bachinsky W, Cambier P et al (2009) A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure’s Vascular Closure Device Speeds Hemostasis Trial). JACC Cardiovasc Interv 2:785–793
Boschewitz JM, Andersson M, Naehle CP et al (2013) Retrospective evaluation of safety and effectiveness of the EXOSEAL vascular closure device for single vascular closure and closure after repeat puncture in diagnostic and interventional radiology: single-center experience. J Vasc Interv Radiol 24:698–702
Schmelter C, Liebl A, Poullos N, Ruppert V, Vorwerk D (2013) Suitability of Exoseal vascular closure device for antegrade femoral artery puncture site closure. Cardiovasc Intervent Radiol 36:659–668
Visona A, Tonello D, Zalunardo B et al (2009) Antithrombotic treatment before and after peripheral artery percutaneous angioplasty. Blood Transfus 7(1):18–23
Sacks D, Marinelli DL, Martin LG, Spies JB, Society of Interventional Radiology Technology Assessment Committee (2003) Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 14:S395–S404
Looby S, Keeling AN, McErlean A et al (2008) Efficacy and safety of the angioseal vascular closure device post antegrade puncture. Cardiovasc Intervent Radiol 31:558–562
Minko P, Katoh M, Graber S, Bueckeret A (2012) Obesity: an independent risk factor for insufficient hemostasis using the AngioSeal vascular closure device after antegrade puncture. Cardiovasc Intervent Radiol 35:775–778
Conflict of interest
Uri Rimon, Boris Khaitovich, Dmitry Yakubovitch, Paul Bensaid, Gil Golan, and Daniel Silverberg have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rimon, U., Khaitovich, B., Yakubovich, D. et al. The Use of ExoSeal Vascular Closure Device for Direct Antegrade Superficial Femoral Artery Puncture Site Hemostasis. Cardiovasc Intervent Radiol 38, 560–564 (2015). https://doi.org/10.1007/s00270-014-0984-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-014-0984-0